Research Library
Cosmetic

GHK-Cu

Sequence length
3 aa + Cu²⁺
Molecular weight
402.92 g/mol
Half-life
minutes (plasma)
Discovered
1973

Overview

GHK-Cu is the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, first isolated from human plasma in 1973 by Loren Pickart. Endogenous concentrations decline measurably with age, which catalysed early interest in the molecule as a regenerative signal.

The peptide's affinity for Cu(II) is unusually high — it acts as a physiological copper shuttle, moving the ion across cell membranes in a chemically protected form. Many of the documented biological effects of GHK depend on the bound copper.

Decades of dermatological research have established GHK-Cu as a credible modulator of dermal remodelling, with effects on collagen synthesis, glycosaminoglycan production and antioxidant gene expression. It is one of the better-characterised cosmetic peptides in the literature.

Mechanism of Action

peptidereceptor

GHK binds Cu(II) with picomolar affinity, forming a planar coordination complex that is selectively recognised by copper-transporting machinery on the cell surface. Once delivered, the copper participates in redox reactions and as a cofactor for lysyl-oxidase, the enzyme that cross-links collagen and elastin.

Independently of copper delivery, the GHK sequence has been shown to modulate gene expression on a broad scale. Microarray studies report up- and down-regulation of hundreds of genes involved in wound healing, antioxidant defence, and tissue remodelling.

Topical application increases dermal fibroblast proliferation and collagen-I deposition in controlled studies, and accelerates wound contraction in animal models of full-thickness skin injury.

Copper carrier
Picomolar Cu(II) binding; delivers copper to enzymes.
Gene modulation
Broad effect on wound-healing and antioxidant gene sets.
Best evidence
Topical effects on collagen and wound contraction.

Research Summary

  • Stimulated collagen synthesis in fibroblast cultures treated with the GHK-copper(II) complex. [1]
  • Improved wound-healing outcomes and fibroblast activity in copper-peptide-treated skin models. [2]
  • Broad modulation of skin-regeneration gene pathways, including antioxidant and remodeling-related genes. [3]
  • Review evidence for chemoattraction of repair cells, anti-inflammatory activity and broad tissue-remodeling effects. [4]

What we don't know yet

  • Systemic effects of injected GHK-Cu in humans are poorly studied compared to topical use.
  • Long-term safety of chronic high-dose exposure remains uncharacterised.
  • Comparative efficacy versus established retinoid and growth-factor cosmetics is rarely measured head-to-head.

Protocol Considerations

Research framing only. The Protides Research Library does not provide dosing guidance for human use. The figures below summarise published research-protocol ranges and storage conditions; they are not clinical recommendations.

Stack Interactions

BPC-157
Complementary remodelling pathways in connective-tissue research.
TB-500
Angiogenesis + dermal regeneration synergy in animal wound models.

Storage & Handling

Lyophilised
−20 °C, desiccated, protected from light (copper photoreactivity).
Reconstituted
2–8 °C in sterile water; copper-peptide solutions degrade faster than copper-free peptides.
Shelf life
Lyophilised ≥ 24 months at −20 °C. Reconstituted ~7–10 d at 2–8 °C.

FAQ

Does GHK-Cu work without the copper?

The peptide has measurable activity without copper, but most of the well-replicated effects (collagen, lysyl oxidase) depend on the bound ion.

Is it more effective topically or systemically?

Topical evidence is much more robust. Systemic data in humans is sparse.

Why does the reconstituted solution turn blue?

Cu(II) coordinated to the peptide absorbs in the orange band, producing a characteristic blue colour. Loss of colour suggests degradation.

Is it approved for any clinical use?

Not as a regulated drug. It appears in many cosmetic formulations under various trade names.

Does GHK-Cu help with hair growth?

Ex vivo and small clinical studies report effects on dermal papilla cells, but large controlled trials are lacking.

Is it safe to combine with vitamin C topically?

High-dose ascorbate can reduce Cu(II) to Cu(I) and disrupt the complex; the two are often best applied at different times of day.

References

  1. [1]
  2. [2]
  3. [3]
  4. [4]
    The human tri-peptide GHK and tissue remodeling
    J. Biomater. Sci. Polym. Ed., 2008
Talk to our ambassador
on WhatsApp